Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Ophthalmology Physician in Newport Beach, CA
NPI: 1114025780Primary Practice Location
Newport Beach Surgery Center
361 Hospital Rd, Newport Beach, CA
Primary Employer
Visionary Eye Institute Inc
visionaryeyeinstitute.com
HQ Phone
Get M.D. Ehsan's Phone Numberphone_androidMobile
Get M.D. Ehsan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2004 - 2026
American Board of Ophthalmology
Ophthalmology
University Of Michigan Medical School
medschool.umich.edu
Medical School
Until 2000
University of Maryland
Residency • Ophthalmology
2001 - 2004
Arrowhead Regional Medical Center
Internship • Transitional Year
2000 - 2001
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 146 | 251 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 127 | 175 |
| 3 | 92004Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 104 | 104 |
| 4 | 92133Diagnostic imaging of optic nerve of eye | 89 | 101 |
| 5 | 92083Measurement of field of vision during daylight conditions | 83 | 88 |
The Prevalence of Demodex Blepharitis in US Eye Care Clinic Patients as Determined by Collarettes: A Pathognomonic Sign.
Authors: William Trattler
Publication Date: 2021-12-23
Lead Sponsor: Tarsus Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle control, DRUG: Lotilaner ophthalmic solution, 0.25%
Lead Sponsor: Novoxel Ltd.
Intervention / Treatment: DEVICE: LipiFlow, DEVICE: Tixel C
Lead Sponsor: Tarsus Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: TP-03 Vehicle, DRUG: TP-03
